Quick answer: Epitalon, NAD+, and MOTS-c are three of the most-studied compounds in longevity research, and they target different mechanisms of cellular aging. Epitalon is studied for telomerase activation (telomere maintenance), NAD+ for cellular energy and DNA-repair metabolism, and MOTS-c for mitochondrial and metabolic regulation. Together they map to three separate hallmarks of aging. Sold for research use only.
The framework: three hallmarks, three compounds
Longevity research is often organized around the López-Otín “hallmarks of aging” framework. These three compounds are interesting precisely because they address different hallmarks, which is why they’re frequently researched as a complementary stack rather than alternatives:
| Compound | Hallmark of aging addressed | What the research explores |
|---|---|---|
| Epitalon | Telomere attrition | Telomerase (hTERT) activation and telomere-length maintenance; circadian/pineal regulation |
| NAD+ | Deregulated nutrient sensing / energy metabolism | Coenzyme for mitochondrial electron transport and sirtuin/DNA-repair pathways |
| MOTS-c | Mitochondrial dysfunction | Mitochondrial-derived peptide regulating metabolic homeostasis and exercise capacity |
What each is studied for
Epitalon (Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for its ability to activate telomerase reverse transcriptase (hTERT), the enzyme that maintains telomere length. Russian longevity studies (Khavinson and colleagues) reported telomerase-activity increases on the order of 33–45% in treated subjects, alongside research interest in circadian/melatonin regulation via the pineal gland.
NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme required for hundreds of enzymatic reactions, including the entire mitochondrial electron-transport chain and the sirtuin pathways that link energy metabolism to DNA repair and epigenetic regulation. NAD+ research sits at the nutrient-sensing/energy-metabolism hallmark.
MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial genome. It is studied as an exercise-induced regulator of metabolic homeostasis, insulin sensitivity, and age-dependent physical decline — placing it at the mitochondrial-dysfunction hallmark.
Why they’re researched as a stack
Because each addresses a distinct, independent dimension of cellular aging — telomere maintenance, metabolic/energy function, and mitochondrial regulation — the literature treats them as additive. Epitalon maintains replicative capacity while NAD+ maintains metabolic function and MOTS-c supports mitochondrial signaling. SS-31 (elamipretide), a mitochondria-targeted peptide, is often referenced alongside them for cardiolipin/mitochondrial-membrane research.
Frequently asked questions
What is the difference between Epitalon, NAD+, and MOTS-c?
They target different aging mechanisms: Epitalon is studied for telomerase activation and telomere length, NAD+ for cellular energy metabolism and DNA repair, and MOTS-c for mitochondrial and metabolic regulation.
Why are these three studied together?
Each maps to a separate hallmark of aging — telomere attrition, deregulated nutrient sensing, and mitochondrial dysfunction — so researchers study them as complementary rather than competing.
What does Epitalon do in research?
It is researched for activating telomerase (hTERT) to maintain telomere length, with reported telomerase-activity increases of roughly 33–45% in published studies, plus circadian-regulation research.
What is MOTS-c?
A peptide encoded in the mitochondrial genome that is studied as a regulator of metabolic homeostasis, insulin sensitivity, and exercise-related physical decline.
Is NAD+ a peptide?
No — NAD+ is a coenzyme, not a peptide, but it’s central to longevity research because it powers mitochondrial energy production and sirtuin/DNA-repair pathways.
Primary-literature anchors
Cite primary sources rather than vendor blogs: López-Otín et al., “The Hallmarks of Aging” (Cell, 2013; updated 2023); Lee et al., MOTS-c as a mitochondrial-derived regulator (Cell Metabolism, 2015); Khavinson et al. on Epitalon/telomerase (Bulletin of Experimental Biology and Medicine). Link via PubMed.
For research use only. Not for human or veterinary use, diagnosis, treatment, or prevention of any condition. Not evaluated by the FDA. Author: Charles Fowler. Last updated: May 2026.